Qiuxiang Ou

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 21

Top Venues

Cancer medicine

Molecular oncology

The journal of pathology. Clinical research

OncoTargets and therapy

Geneseeq Technology Inc.

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Geneseeq Technology Inc. Aug 01 2019

Canada

Senior Scientist/Team Lead :: Translational Medicine

University of Alberta May 15 2013 - Aug 01 2016

Canada

Postdoctoral fellow :: Biological Sciences

Publications

Yi Sun, Shilei Qin, Song Wang, Jiaohui Pang, Qiuxiang Ou, Weiquan Liang, Hai Zhong
Comprehensive genomic profiling of pulmonary spindle cell carcinoma using tissue and plasma samples: insights from a real-world cohort analysis. The journal of pathology. Clinical research 10 (3) (2024)
Yi Sun, Shilei Qin, Song Wang, Jiaohui Pang, Qiuxiang Ou, Weiquan Liang, Hai Zhong
Comprehensive genomic profiling of pulmonary spindle cell carcinoma using tissue and plasma samples: insights from a real-world cohort analysis. The journal of pathology. Clinical research 10 (3) (2024)
Enrique Sanz-Garcia, Sofia Genta, Xiaoxi Chen, Qiuxiang Ou, Daniel Vilarim Araújo, Albiruni Abdul Razak, Aaron Richard Hansen, Anna Spreafico, Hua Bao, Xue Wu, Lillian L Siu, Philippe L Bedard
Tumor-Naïve Circulating Tumor DNA as an Early Response Biomarker for Patients Treated With Immunotherapy in Early Phase Clinical Trials. JCO precision oncology 7 (2023)
Hai-Yan Tu, Kai Yin, Xiaotian Zhao, E-E Ke, Si-Pei Wu, Yang-Si Li, Mei-Mei Zheng, Si-Yang Maggie Liu, Chong-Rui Xu, Yue-Li Sun, Jia-Xin Lin, Xiao-Yan Bai, Yi-Chen Zhang, Qing Zhou, Jin-Ji Yang, Wen-Zhao Zhong, Bing-Chao Wang, Xu-Chao Zhang, Dongqin Zhu, Lingling Yang, Qiuxiang Ou, Yi-Long Wu
Genomic and immune characteristics of HER2-mutated non-small cell lung cancer and response to immune checkpoint inhibitor-based therapy. Molecular oncology (2023)
Jun Pu, Huannan Guo, Ruoying Yu, Qiuxiang Ou, Hua Bao, Xue Wu, Sanyuan Tang, Qingyong Chang
Pan-cancer molecular analysis of EGFR large fragment deletion in the Asian population. Cancer medicine (2023)
Cunte Chen, Si-Yang Maggie Liu, Yuchen Han, Ming Han, Qiuxiang Ou, Hua Bao, Ling Xu, Yi-Kai Zhang, Wen-Zhao Zhong, Wen-Zhao Zhong, Qing Zhou, Xue-Ning Yang, Yang W Shao, Yi-Long Wu, Si-Yang Liu, Yangqiu Li
Poor prognosis of intra-tumoural TRBV6-6 variants in EGFR-mutant NSCLC: Results from the ADJUVANT-CTONG1104 trial. Clinical and translational medicine 12 (4) (2022)
Hui Wang, Zhi-Wei Li, Qiuxiang Ou, Xue Wu, Misako Nagasaka, Yang Shao, Sai-Hong Ignatius Ou, Yu Yang
NTRK fusion positive colorectal cancer is a unique subset of CRC with high TMB and microsatellite instability. Cancer medicine 11 (13) (2022)
Xiaojing Lai, Ruoying Yu, Qiuxiang Ou, Hua Bao, Xue Wu, Yang Shao, Yang Li, Ying Zhang, Qingqing Ding
Clinical and molecular characteristics of kinase domain duplications across diverse cancer types in the Chinese population. Cancer medicine (2022)
Yue Li, Chong Li, Ya Jiang, Xue Han, Sisi Liu, Xiuxiu Xu, Wanxiangfu Tang, Qiuxiang Ou, Hua Bao, Xue Wu, Yang W Shao, Minyan Xing, Yixiang Zhang, Yuezhen Wang
Correlation of PD-L1 Expression with Clinicopathological and Genomic Features in Chinese Non-Small-Cell Lung Cancer. Journal of oncology 2022 (2022)
Lanxin Zhang, Siwen Sun, Xiaotian Zhao, Jingwen Liu, Yang Xu, Lingzhi Xu, Chen Song, Na Li, Jing Yu, Shanshan Zhao, Peiyao Yu, Fengqi Fang, Jiping Xie, Xuening Ji, Ruoying Yu, Qiuxiang Ou, Zuowei Zhao, Man Li
Prognostic value of baseline genetic features and newly identified TP53 mutations in advanced breast cancer. Molecular oncology 16 (20) (2022)
Cunte Chen, Si-Yang Maggie Liu, Yuchen Han, Qiuxiang Ou, Hua Bao, Ling Xu, Yi-Kai Zhang, Wen-Zhao Zhong, Wen-Zhao Zhong, Qing Zhou, Xue-Ning Yang, Yang W Shao, Yi-Long Wu, Si-Yang Liu, Yangqiu Li
Identification of TCR rearrangements specific for genetic alterations in EGFR-mutated non-small cell lung cancer: results from the ADJUVANT-CTONG1104 trial. Cancer immunology, immunotherapy : CII (2022)
Xiaomeng Jia, Shanshan Zhao, Xiang Li, Li Lv, Xin Chen, Evenki Pan, Qiuxiang Ou, Chen Song, Siwen Sun, Jinbo Zhao, Lingzhi Xu, Man Li
Favorable Response to Olaparib in a Patient with Cancer of Unknown Primary Carrying a Germline BRCA1 R71K Mutation. OncoTargets and therapy 14 (2021)
Yingying Huang, Wenzhuo Jia, Lijun Wang, Qiuxiang Ou, Xue Wu, Baocai Xing
Clearance of circulating tumor DNA in a high-risk stage-IV rectal carcinoma patient with synchronous liver metastases after conversion surgery is correlated with pathologic complete response. Therapeutic advances in gastrointestinal endoscopy 14 (2021)
Yun Fan, Jinrong Qiu, Ruoying Yu, Ran Cao, Xiaoxi Chen, Qiuxiang Ou, Xue Wu, Yang W Shao, Misako Nagasaka, Jiexia Zhang, Sai-Hong Ignatius Ou
Clinical and molecular characteristics of Chinese non-small cell lung cancer patients with ERBB2 transmembrane domain mutations. Molecular oncology 14 (8) (2020)
Zhengyun Zou, Qiuxiang Ou, Yu Ren, Qing Lv, Lanqun Qin, Lianjun Zhao, Shu Su, Xue Wu, Hua Bao, Ao Wang, Dongqin Zhu, Xiaonan Wang, Yang W Shao, Baorui Liu
Distinct genomic traits of acral and mucosal melanomas revealed by targeted mutational profiling. Pigment cell & melanoma research 33 (4) (2020)
Zhibo Zhang, Fan Zhang, Fang Yuan, Ye Li, Junxun Ma, Qiuxiang Ou, Zhefeng Liu, Bo Yang, Lijie Wang, Haitao Tao, Sujie Zhang, Xiaoyan Li, Xiaoyu Zhi, Xiangwei Ge, Hua Bao, Xue Wu, Yi Hu, Jinliang Wang
Pretreatment hemoglobin level as a predictor to evaluate the efficacy of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer. Therapeutic advances in medical oncology 12 (2020)
Meiying Cui, Yuchen Han, Pan Li, Jianying Zhang, Qiuxiang Ou, Xiaoling Tong, Ruiying Zhao, Nan Dong, Xue Wu, Wencai Li, Guozhong Jiang
Molecular and clinicopathological characteristics of ROS1-rearranged non-small-cell lung cancers identified by next-generation sequencing. Molecular oncology 14 (11) (2020)
Feili Chen, Diwen Pang, Hanguo Guo, Qiuxiang Ou, Xue Wu, Xinmiao Jiang, Xiaojuan Wei, Sichu Liu, Ling Huang, Zhanli Liang, Dong Zhou, Wenyu Li
Clinical outcomes of newly diagnosed primary CNS lymphoma treated with ibrutinib-based combination therapy: A real-world experience of off-label ibrutinib use. Cancer medicine 9 (22) (2020)
Hong-Sheng Wang, Qiuxiang Ou, Delan Li, Tao Qin, Hua Bao, Xue Hou, Kaicheng Wang, Fang Wang, Qianqian Deng, Jianzhong Liang, Wei Zheng, Xue Wu, Xiaonan Wang, Yang W Shao, Yonggao Mou, Li-Kun Chen
Genes associated with increased brain metastasis risk in non-small cell lung cancer: Comprehensive genomic profiling of 61 resected brain metastases versus primary non-small cell lung cancer (Guangdong Association Study of Thoracic Oncology 1036). Cancer 125 (20) (2019)
Jinguang Wang, Xingya Li, Xingyang Xue, Qiuxiang Ou, Xue Wu, Ying Liang, Xiaonan Wang, Ming You, Yang W Shao, Zhihong Zhang, Shucai Zhang
Clinical outcomes of EGFR kinase domain duplication to targeted therapies in NSCLC. International journal of cancer 144 (11) (2018)
Outa Uryu, Qiuxiang Ou, Tatsuya Komura-Kawa, Takumi Kamiyama, Masatoshi Iga, Monika Syrzycka, Keiko Hirota, Hiroshi Kataoka, Barry M Honda, Kirst King-Jones, Ryusuke Niwa
Cooperative Control of Ecdysone Biosynthesis in Drosophila by Transcription Factors Séance, Ouija Board, and Molting Defective. Genetics 208 (2) (2017)

Qiuxiang Ou.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Qiuxiang Ou